Johnson & Johnson (NYSE: JNJ) is scheduled to report its third-quarter financial results before the markets open on Tuesday. The consensus estimates are calling for $2.03 in earnings per share (EPS) and $20.05 billion in revenue. The same period of last year reportedly had $1.90 in EPS and $19.65 billion in revenue.
The firm’s strong second-quarter results reflected double-digit growth in its Pharmaceutical business and the accelerating sales momentum in its Medical Devices business, driven by the continued growth of its market-leading products and strategic new launches.
Alex Gorsky, board chair and chief executive, commented in the second quarter:
We remain focused on investing in innovation and meeting the needs of our customers by delivering innovative products and solutions that position the company to deliver long-term, sustainable growth. Our talented J&J colleagues are united in our efforts to address some of the most critical health and consumer needs of people around the world.
Also at that time, Johnson & Johnson updated its full-year guidance. The company now expects to see EPS in the range of $8.07 to $8.17 and revenues between $80.5 billion and $81.3 billion. The consensus estimates now are $8.15 in EPS and revenue of $81.23 billion for the year.
Overall, Johnson & Johnson has underperformed the broad markets, with the stock down 2% in the past 52 weeks. In just 2018 alone, the stock is down 4%.
A few analysts weighed in on Johnson & Johnson ahead of the report:
- Credit Suisse has a Buy rating with a $149 price target.
- Wells Fargo has an Outperform rating and a $160 target.
- Jefferies has a Buy rating with a $145 price target.
- Goldman Sachs has a Neutral rating.
Johnson & Johnson shares were last seen trading at $133.95, with a consensus analyst price target of $144.32 and a 52-week trading range of $118.62 to $148.32.
24/7 Wall St.Take This Retirement Quiz To Get Matched With A Financial Advisor (Sponsored)
Take the quiz below to get matched with a financial advisor today.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the
advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Take the retirement quiz right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
